Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression
Guohe Song(Fudan University), Qiang Gao(Northeastern University), Jiaqiang Ma(Ministry of Education), Zijie Jin(Peking University), Juan Zhang(Fudan University), Shyamal Goswami(Institut Pasteur of Shanghai), Yang Shi(Guiyang College of Traditional Chinese Medicine), Ai‐Wu Ke(Fudan University), Saifullah Afridi(Chinese Academy of Sciences), Jian Zhou(Shenzhen University Health Science Center), Ruibin Xi(Peking University), Youpei Lin(Zhongshan Hospital), Yi Chen(Sun Yat-sen University), Shu Zhang(Tianjin University of Technology), Xiaoming Zhang(Shanghai Medical College of Fudan University), Yuming Liu(Nankai University), Ya Cao(Shanghai University), Jia Fan(Nanjing Tech University), Xiaoying Wang(Fudan University), Meiying Zhang(Fujian Medical University), Meng Lu(Fudan University), Shuaixi Yang(Fudan University), Dongning Rao(Fudan University)
Cited by 193
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
|Cancer Cell|2017|656
A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
|Journal of Ovarian Research|2014|545